Primoris Services just reported Q2 results, and the question the market now has to answer is whether the 15% weekly rally was justified by what came through in the print — or whether it ran ahead of the fundamentals.
The earnings-day price reaction tells a partial story. The one data point available from the prior quarter shows the stock moved roughly 7.6% on the day of its August 3 release. What's notable is how sharply options positioning shifted into that event: the put/call ratio collapsed to 0.21, more than two standard deviations below its 20-day average of 0.28, and near the lowest reading of the past year. Calls outnumbered puts by nearly five to one heading into the print — a clear statement from options traders that the market was positioned for good news, not bracing for a miss.
The lending market adds no drama here. Availability remains above 970%, meaning borrow is abundant. Short interest at 5.7% of the free float is a real but moderate position. Critically, it has been falling — down more than 15% over the past month, from roughly 4 million shares to just over 3 million — suggesting shorts have been covering steadily since late June. Cost to borrow is running at 0.42%, a low absolute level despite creeping up about 16% on the week. This is a borrow market that reflects no panic, no squeeze, and no crowding on either side.
The Street came into earnings with a noticeably divided view. Two prominent houses — Goldman Sachs and JP Morgan — both upgraded the stock in late June, with Goldman moving from Sell to Neutral and JPM shifting to Overweight at $116. Against that, a cluster of firms including Wells Fargo, Mizuho, and Needham trimmed their targets in mid-to-late June, with Wells Fargo cutting all the way to $85 — now below the current price of $90.85. Cantor Fitzgerald reiterated Neutral with a $100 target just today. The mean analyst target is $127.50, implying roughly 40% upside from here on the consensus view, though the spread between the bulls (Needham at $172, Guggenheim at $162) and the bears ($85–$100 range) is exceptionally wide. That disagreement is the story: this is not a stock where the Street has settled on a verdict.
The fundamental debate maps cleanly onto that spread. Bulls rest their case on the PayneCrest acquisition expanding electrical infrastructure capabilities, a strong utility-linked backlog, and exposure to the long-cycle energy transition buildout. The bear case centres on execution risk in solar — cost overruns, project delays, and management's own admission that geographic unfamiliarity caused problems. The factor scores sit uneasily in the middle: analyst recommendation divergence ranks in the 93rd percentile of the universe, meaning professional opinion is more dispersed on this name than almost any comparable stock. EPS momentum scores are weak, ranking in the 13th and 3rd percentiles on 30-day and 90-day windows respectively, and the 12-month forward EPS trend ranks in just the 2nd percentile — suggesting estimate revisions have been running decisively against the stock even as the share price found footing.
First Trust added roughly 928,000 shares in the quarter to June 30, becoming one of the larger incremental buyers among institutional holders. BlackRock also added around 220,000 shares in the same period. On the insider side, the most recent activity — dating to late May — was mixed: the President and CEO purchased approximately $1 million worth of stock at around $128, while both the Chief Legal Officer and the Chairman sold meaningfully at similar price levels. That the CEO bought while the stock traded above $125 and the name is now at $90 gives the purchase a different complexion — either conviction that the business recovers, or an early entry that has yet to play out.
The next earnings date is November 2. Between now and then, the conversation is less about whether Primoris can grow and more about whether the Q2 print — and whatever management said on the call — offers enough evidence that the solar execution problems are genuinely behind it rather than still embedded in the backlog.
See the live data behind this article on ORTEX.
Open PRIM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.